Literature DB >> 31296369

Global brain inflammation in stroke.

Kaibin Shi1, De-Cai Tian2, Zhi-Guo Li3, Andrew F Ducruet4, Michael T Lawton4, Fu-Dong Shi5.   

Abstract

Stroke, including acute ischaemic stroke and intracerebral haemorrhage, results in neuronal cell death and the release of factors such as damage-associated molecular patterns (DAMPs) that elicit localised inflammation in the injured brain region. Such focal brain inflammation aggravates secondary brain injury by exacerbating blood-brain barrier damage, microvascular failure, brain oedema, oxidative stress, and by directly inducing neuronal cell death. In addition to inflammation localised to the injured brain region, a growing body of evidence suggests that inflammatory responses after a stroke occur and persist throughout the entire brain. Global brain inflammation might continuously shape the evolving pathology after a stroke and affect the patients' long-term neurological outcome. Future efforts towards understanding the mechanisms governing the emergence of so-called global brain inflammation would facilitate modulation of this inflammation as a potential therapeutic strategy for stroke.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31296369     DOI: 10.1016/S1474-4422(19)30078-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  117 in total

1.  miR-671-5p Attenuates Neuroinflammation via Suppressing NF-κB Expression in an Acute Ischemic Stroke Model.

Authors:  Ling Deng; Yi Guo; Jingdong Liu; Xuan Wang; Sha Chen; Qian Wang; Jianyan Rao; Yuchun Wang; Tianrui Zuo; Qingwen Hu; Xiahong Zhao; Zhi Dong
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

2.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke.

Authors:  Masanori Gomi Naito; Daichao Xu; Palak Amin; Jinwoo Lee; Huibing Wang; Wanjin Li; Michelle Kelliher; Manolis Pasparakis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

3.  Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition.

Authors:  Baokai Dou; Shichun Li; Luyao Wei; Lixin Wang; Shiguo Zhu; Zhengtao Wang; Zunji Ke; Kaixian Chen; Zhifei Wang
Journal:  Front Med       Date:  2020-12-28       Impact factor: 4.592

4.  Neuropathic pain releasing calcitonin gene related peptide protects against stroke in rats.

Authors:  Yida Wang; Zhenxiu Liu; Xinyu Ge; Xinyu Hu; Xiangyuan Cao; Lei Li; Jianhua Xia; Fulong Li; Liang Gao
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

5.  The Protective Effect of PK-11195 on Cognitive Impairment in Rats Survived of Polymicrobial Sepsis.

Authors:  Diogo Dominguini; Amanda V Steckert; Mariane R Abatti; Jaqueline S Generoso; Tatiana Barichello; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

Review 6.  Monoclonal antibody as an emerging therapy for acute ischemic stroke.

Authors:  Demi Woods; Qian Jiang; Xiang-Ping Chu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-08-25

Review 7.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

8.  Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.

Authors:  Guomei Shi; Minghao Li; Rujuan Zhou; Xiaorong Wang; Wu Xu; Feng Yang; Shouru Xue
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

Review 9.  Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design.

Authors:  Luda Feng; Fang Han; Li Zhou; Shengxian Wu; Yawei Du; Dandan Zhang; Chi Zhang; Ying Gao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

10.  Systematic Study of Immune Cell Diversity in ischemic postconditioning Using High-Dimensional Single-Cell Analysis with Mass Cytometry.

Authors:  Yang Yao; Yaning Li; Weihua Ni; Zhijun Li; Liangshu Feng; Yan Wang; Jihong Meng; Heng Zhao
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.